Decision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran
- PMID: 33263246
- PMCID: PMC7779976
- DOI: 10.3947/ic.2020.52.4.496
Decision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran
Abstract
To provide a step-by-step approach to chemotherapy (CTx) in the novel coronavirus disease 2019 (COVID-19) era. The COVID-19 pandemic is the current global issue resulting in vast health implications. Amid the COVID-19 era, special attention must be paid to at-risk groups, including patients with cancer. To our knowledge, there is a paucity of data on the decision for CTx during the pandemic. We herein provide practical recommendations on the CTx of cancer patients over the pandemic based on our experience in an educational hospital. The decision on CTx should be considered to be individualized based on clinical findings. We hope that our experience provides a practical guide for clinical oncologists to deliver more effective cancer care over the COVID-19 pandemic.
Keywords: COVID-19; Cancer; Chemotherapy.
Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Conflict of interest statement
No conflicts of interest.
Figures
References
-
- Johns Hopkins University and Medicine. COVID-19 mortality rate. [Accessed 1 September 2020]. Available at: https://coronavirus.jhu.edu/map.html.
-
- Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini AC, Bria E, Brighenti M, Cadranel J, De Toma A, Chini C, Cortellini A, Felip E, Finocchiaro G, Garrido P, Genova C, Giusti R, Gregorc V, Grossi F, Grosso F, Intagliata S, La Verde N, Liu SV, Mazieres J, Mercadante E, Michielin O, Minuti G, Moro-Sibilot D, Pasello G, Passaro A, Scotti V, Solli P, Stroppa E, Tiseo M, Viscardi G, Voltolini L, Wu YL, Zai S, Pancaldi V, Dingemans AM, Van Meerbeeck J, Barlesi F, Wakelee H, Peters S, Horn L TERAVOLT investigators. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21:914–922. - PMC - PubMed
-
- Soroosh D, Javadinia SA. The COVID-19 outbreak and Oncology Centers in Iran. Int J Cancer Manag. 2020 [Epub ahead of print]
